Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nutt

Showing results (301-310 of 789) with videos related to

Pageof 79
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|April 11, 2001
Exacerbated physical fatigue and mental fatigue in Parkinson's diseaseJ S Lou, G Kearns, B Oken, et al.
Journal of Psychopharmacology (Oxford, England)|September 30, 2003
Caffeine and central noradrenaline: effects on mood, cognitive performance, eye movements and cardiovascular functionAndrew Smith, Carolyn Brice, Jon Nash, et al.
Neurochemical Research|November 1, 1988
The effect of acute and chronic electroconvulsive shock on [3H]phorbol-dibutyrate binding to rat brain membranesC H Gleiter, J Deckert, D J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|February 24, 2001
Sleep and daytime sleepiness the next day following single night-time dose of fluvoxamine, dothiepin and placebo in normal volunteersS J Wilson, J E Bailey, C Alford, et al.
Journal of Psychopharmacology (Oxford, England)|February 4, 2012
Discriminative stimulus produced by the imidazoline I2 site ligand, 2 -BFIS Jordan, H C Jackson, D J Nutt, et al.
Psychopharmacology|March 17, 2006
Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopramInnar Tõru, Jakov Shlik, Eduard Maron, et al.
Psychopharmacology|January 1, 1993
Central alpha-2 adrenoceptors are responsible for a clonidine-induced cue in a rat drug discrimination paradigmS Jordan, H C Jackson, D J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|March 30, 2013
Amphetamine, past and present--a pharmacological and clinical perspectiveDavid J Heal, Sharon L Smith, Jane Gosden, et al.
The International Journal of Neuropsychopharmacology|December 6, 2002
Generalized anxiety disorder: comorbidity, comparative biology and treatmentDavid J Nutt, James C Ballenger, David Sheehan, et al.
Annals of the New York Academy of Sciences|July 23, 1999
Inhibition of central monoamine oxidase by imidazoline2 site-selective ligandsM D Lalies, A Hibell, A L Hudson, et al.
Pageof 79

Showing results (301-310 of 789) with videos related to

Sort By:
Pageof 79
Movement Disorders : Official Journal of the Movement Disorder Society|April 11, 2001
Exacerbated physical fatigue and mental fatigue in Parkinson's diseaseJ S Lou, G Kearns, B Oken, et al.
Journal of Psychopharmacology (Oxford, England)|September 30, 2003
Caffeine and central noradrenaline: effects on mood, cognitive performance, eye movements and cardiovascular functionAndrew Smith, Carolyn Brice, Jon Nash, et al.
Neurochemical Research|November 1, 1988
The effect of acute and chronic electroconvulsive shock on [3H]phorbol-dibutyrate binding to rat brain membranesC H Gleiter, J Deckert, D J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|February 24, 2001
Sleep and daytime sleepiness the next day following single night-time dose of fluvoxamine, dothiepin and placebo in normal volunteersS J Wilson, J E Bailey, C Alford, et al.
Journal of Psychopharmacology (Oxford, England)|February 4, 2012
Discriminative stimulus produced by the imidazoline I2 site ligand, 2 -BFIS Jordan, H C Jackson, D J Nutt, et al.
Psychopharmacology|March 17, 2006
Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopramInnar Tõru, Jakov Shlik, Eduard Maron, et al.
Psychopharmacology|January 1, 1993
Central alpha-2 adrenoceptors are responsible for a clonidine-induced cue in a rat drug discrimination paradigmS Jordan, H C Jackson, D J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|March 30, 2013
Amphetamine, past and present--a pharmacological and clinical perspectiveDavid J Heal, Sharon L Smith, Jane Gosden, et al.
The International Journal of Neuropsychopharmacology|December 6, 2002
Generalized anxiety disorder: comorbidity, comparative biology and treatmentDavid J Nutt, James C Ballenger, David Sheehan, et al.
Annals of the New York Academy of Sciences|July 23, 1999
Inhibition of central monoamine oxidase by imidazoline2 site-selective ligandsM D Lalies, A Hibell, A L Hudson, et al.
Pageof 79